| Line Item | 2024-07-31 | Y/Y |
|---|---|---|
| Revenue | $980.5M | +8.3% |
| Cost of Revenue | $397.1M | -11.2% |
| Gross Profit | $583.4M | +27.3% |
| R&D Expense | $269.4M | +7.9% |
| SG&A Expense | $167.5M | -1.3% |
| Operating Income | -$52.6M | +64.8% |
| Interest Expense | $6.7M | +0.3% |
| Pre-tax Income | -$26.8M | +80.0% |
| Income Tax | -$20.7M |
| Line Item | 2024-07-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $548.0M | +36.4% |
| Short-term Investments | $455.6M | +14.8% |
| Accounts Receivable | $137.3M | -9.1% |
| Current Assets | $1.30B | +17.8% |
| Total Assets | $2.23B | +9.8% |
| Current Liabilities | $837.6M | +124.4% |
| Long-term Debt | $398.9M | +0.4% |
| Line Item | 2024-07-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $195.7M | +409.8% |
| Capital Expenditures | $6.4M | +9.3% |
| Investing Cash Flow | -$52.4M | -511.9% |
| Financing Cash Flow | $1.1M | +100.4% |
| Free Cash Flow | $189.4M | +481.4% |
| +6.8% |
| Net Income | -$6.1M | +94.5% |
| EPS (Basic) | -$0.07 | +94.9% |
| EPS (Diluted) | -$0.07 | +94.9% |
| Total Liabilities |
| $883.6M |
| +6.7% |
| Stockholders' Equity | $1.34B | +11.9% |